Details of the Drug

General Information of Drug (ID: DMY9U56)

• Drug Name: BC-819

Indication

Disease Entry	ICD 11	Status	REF
Bladder cancer	2C94	Phase 2	[1]
Pancreatic cancer	2C10	Phase 2	[1]

• Cross-matching ID: TTD ID: D0K0KQ
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01413087) Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma. U.S. National Institutes of Health.